These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 23146829)

  • 1. Amino acid substitutions in the Hepatitis C virus core region of genotype 1b in Moroccan patients.
    Brahim I; Ezzikouri S; Mtairag el M; Alaoui R; Nadir S; Pineau P; Benjelloun S
    Infect Genet Evol; 2013 Mar; 14():102-4. PubMed ID: 23146829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of amino-acid polymorphism in the core protein on progression of liver disease in patients infected with hepatitis C virus genotype 1b.
    Kobayashi M; Akuta N; Suzuki F; Hosaka T; Sezaki H; Kobayashi M; Suzuki Y; Arase Y; Ikeda K; Watahiki S; Mineta R; Iwasaki S; Miyakawa Y; Kumada H
    J Med Virol; 2010 Jan; 82(1):41-8. PubMed ID: 19950230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino acid substitutions in hepatitis C virus core region predict hepatocarcinogenesis following eradication of HCV RNA by antiviral therapy.
    Akuta N; Suzuki F; Hirakawa M; Kawamura Y; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2011 Jun; 83(6):1016-22. PubMed ID: 21503914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of amino acid substitutions in the hepatitis C virus genotype 1b core region on liver steatosis and hepatic oxidative stress in patients with chronic hepatitis C.
    Tachi Y; Katano Y; Honda T; Hayashi K; Ishigami M; Itoh A; Hirooka Y; Nakano I; Samejima Y; Goto H
    Liver Int; 2010 Apr; 30(4):554-9. PubMed ID: 19951380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virological and biochemical features in elderly HCV patients with hepatocellular carcinoma: amino acid substitutions in HCV core region as predictor of mortality after first treatment.
    Ogura S; Akuta N; Hirakawa M; Kawamura Y; Yatsuji H; Sezaki H; Hosaka T; Kobayashi M; Suzuki F; Suzuki Y; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
    Intervirology; 2009; 52(4):179-88. PubMed ID: 19546575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino acid substitutions in the hepatitis C Virus core region and lipid metabolism are associated with hepatocarcinogenesis in nonresponders to interferon plus ribavirin combination therapy.
    Seko Y; Akuta N; Suzuki F; Kawamura Y; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
    Intervirology; 2013; 56(1):13-21. PubMed ID: 22907167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of amino acid mutation in hepatitis C virus core region among Japanese volunteer blood donors.
    Furui Y; Hoshi Y; Murata K; Ito K; Suzuki K; Uchida S; Satake M; Mizokami M; Tadokoro K
    J Med Virol; 2011 Nov; 83(11):1924-9. PubMed ID: 21915867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of hepatitis C virus core region in moroccan intravenous drug users.
    Trimbitas RD; Fayssel N; Serghini FZ; Wakrim L; Khyatti M; Essalhi M; Bellefquih AM; Benani A
    J Med Virol; 2016 Aug; 88(8):1376-83. PubMed ID: 26754854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acid substitutions in the hepatitis C virus core region of genotype 1b are the important predictor of severe insulin resistance in patients without cirrhosis and diabetes mellitus.
    Akuta N; Suzuki F; Hirakawa M; Kawamura Y; Yatsuji H; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2009 Jun; 81(6):1032-9. PubMed ID: 19382270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection.
    Chayama K; Tsubota A; Kobayashi M; Okamoto K; Hashimoto M; Miyano Y; Koike H; Kobayashi M; Koida I; Arase Y; Saitoh S; Suzuki Y; Murashima N; Ikeda K; Kumada H
    Hepatology; 1997 Mar; 25(3):745-9. PubMed ID: 9049229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence analysis of NS3 protease gene in clinical strains of hepatitis C virus.
    Lodrini S; Bagaglio S; Canducci F; De Mitri MS; Andreone P; Loggi E; Lazzarin A; Clementi M; Morsica G
    J Biol Regul Homeost Agents; 2003; 17(2):198-204. PubMed ID: 14518724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virological analysis, genotypes and mutational patterns of the HBV precore/core gene in HBV/HCV-related hepatocellular carcinoma.
    De Mitri MS; Cassini R; Morsica G; Bagaglio S; Andreone P; Loggi E; Muratori P; Bernardi M
    J Viral Hepat; 2006 Sep; 13(9):574-81. PubMed ID: 16907843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nucleotide sequence variation detection system for the core region of hepatitis C virus-1b.
    Okamoto K; Akuta N; Kumada H; Kobayashi M; Matsuo Y; Tazawa H
    J Virol Methods; 2007 Apr; 141(1):1-6. PubMed ID: 17184852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients.
    Missale G; Cariani E; Lamonaca V; Ravaggi A; Rossini A; Bertoni R; Houghton M; Matsuura Y; Miyamura T; Fiaccadori F; Ferrari C
    Hepatology; 1997 Sep; 26(3):792-7. PubMed ID: 9303515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa.
    Zeuzem S; Lee JH; Roth WK
    Hepatology; 1997 Mar; 25(3):740-4. PubMed ID: 9049228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virological features of hepatitis C virus infection in patients with liver diseases in the inshore area of the Yangtze River.
    Yao DF; Horie C; Horie T; Shimizu I; Meng XY; Ito S
    Tokushima J Exp Med; 1994 Jun; 41(1-2):49-56. PubMed ID: 7524191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of hepatitis C amino acid substitutions 70 and 91 in the core coding region by real-time amplification refractory mutation system reverse transcription-polymerase chain reaction.
    Nakamoto S; Kanda T; Yonemitsu Y; Arai M; Fujiwara K; Fukai K; Kanai F; Imazeki F; Yokosuka O
    Scand J Gastroenterol; 2009; 44(7):872-7. PubMed ID: 19424931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and clinical features of hepatitis C virus type 6 infections in blood donors from Hong Kong.
    Prescott LE; Simmonds P; Lai CL; Chan NK; Pike I; Yap PL; Lin CK
    J Med Virol; 1996 Oct; 50(2):168-75. PubMed ID: 8915883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of hepatitis C virus core encoding sequences in chronically infected patients reveals mutability, predominance, genetic history and potential impact on therapy of Cuban genotype 1b isolates.
    González-Horta EE; Marante J; Amador-Cañizares Y; Alvarez-Lajonchere L; Guerra I; Martínez-Donato G; Dueñas-Carrera S
    Eur Rev Med Pharmacol Sci; 2011 Nov; 15(11):1320-7. PubMed ID: 22195367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection.
    Enomoto N; Sakuma I; Asahina Y; Kurosaki M; Murakami T; Yamamoto C; Ogura Y; Izumi N; Marumo F; Sato C
    N Engl J Med; 1996 Jan; 334(2):77-81. PubMed ID: 8531962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.